![]() Recurrence-free survival at 1 year was compared between clinically relevant groups using a cox proportional hazard model and the log-rank P-value. Incidence rates, including adjusted and stratified rates, were calculated based on population data from REP. The group noted that they “used the Rochester Epidemiology Project (REP) to identify incident cases,” using the ICHD-3 criteria for the condition and “the REP convention previously shown to be valid and not requiring documentation of 5 independent migraine attacks if the case was otherwise typical.” “The epidemiology of status migrainosus in the general population is not known,” VanderPluym et al wrote. READ MORE: The MiCOAS Project and the Importance of Patient-Reported Outcomes in Migraine The median duration of attack was 5 days (IQR, 4-9), and the other most frequently recorded trigger was stress (16.9% n = 40). 0022).Ĭhronic migraine was recorded in 36.3% (n = 82) of people and aura in 35.7% (n = 76). ![]() Notably, too much/too little sleep-which was among the most commonly reported triggers, by 11.4% (n = 27) of the cohort-was associated with 12-month risk of recurrence (adjusted odds ratio, 3.59 95% CI, 1.58-8.14 P =. Recurrence of status migrainosus was reported by 35 individuals (14.8%) at a median of 58 days (IQR, 23-130) following their initial attack. We identified aberrant sleep patterns, a potentially modifiable risk factor, as a risk factor for 1-year status migrainosus recurrence.” She and colleagues wrote that this “study provides the first population-based perspective on status migrainosus incidence, a diagnosis which may be inherently enriched among persons with chronic migraine. VanderPluym, MD, neurologist, Mayo Clinic. These data were presented at the 2022 American Headache Society (AHS) Annual Scientific Meeting, June 9-11, in Denver, Colorado, by Juliana H. At the time of status presentation, the medications included triptans or ergotamine in 129 cases (55.4%) and/or an opioid-containing analgesic in 43 cases (18.5%). ![]() Individuals with status migrainosus had a median age of 35 years (IQR, 26-47), with 88.6% (n = 210) of the cohort being women. The data collected included incident cases identified as the first physician-encountered case in the record from January 1, 2012, to December 31, 2017. ![]() Notably, too much or too little sleep showed potential predictive ability of status migrainosus recurrence. A study of the overall age- and sex-adjusted incidence of status migrainosus in Olmsted County, Minnesota, identified that the incidence rate of the migraine condition was 26.60 per 100,000 individuals (95% CI, 23.21-29.97), with an estimated 15% of the cohort experiencing a recurrent attack of status migrainosus over the following 12 months. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |